Previous Close | 9.58 |
1-Year Change | 110.55% |
6-Months Change | 5.16% |
3-Months Change | -18.4% |
Moving Avg (50d) | 11.3086 |
Moving Avg (200d) | 11.322 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 268.6M |
Beta (3-Years) | 1.04 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -28.24% |
EPS (ttm) | -2.12 |
PE Ratio (ttm) | -4.52 |
Dividend Yield | % |
Asset Description: | Astria Therapeutics, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-08 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
9.843 | 10.132 | 10.325 | 10.615 | 11.097 | 11.58 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.